Related Experiment Videos

Translational readthrough of an amber termination codon during synthesis of feline leukemia virus protease

Journal of Virology
|September 1, 1985
PubMed

Insights

Feline leukemia virus protease cleaves viral proteins, similar to its murine counterpart. This viral-coded enzyme is located in the pol gene and synthesized via gag gene suppression.

Area of Science:

  • Virology
  • Molecular Biology
  • Biochemistry

Background:

  • Feline leukemia virus (FeLV) is a significant pathogen in cats.
  • Viral proteases are crucial for processing viral polyproteins into functional proteins.
  • Murine leukemia virus (MuLV) protease shares specificity with other retroviral proteases.

Purpose of the Study:

  • To characterize the protease of Feline Leukemia Virus (FeLV).
  • To determine the enzymatic specificity and genetic location of the FeLV protease.
  • To elucidate the synthesis mechanism of the FeLV protease.

Main Methods:

  • In vitro cleavage assays using Gazdar-mouse sarcoma virus Pr65gag substrate.
  • Purification of the FeLV protease.
  • Determination of the NH2-terminal amino acid sequence of the protease.
  • Alignment of amino acid sequence with viral nucleotide sequence.

Main Results:

  • FeLV protease exhibits similar cleavage specificity to MuLV protease.
  • The protease cleaves Pr65gag into mature proteins: p15, p12, p30, and p10.
  • FeLV protease is a viral-coded enzyme located at the 5' end of the pol gene.
  • Synthesis involves in-frame suppression of the gag amber termination codon, with the first four amino acids from the gag gene.

Conclusions:

  • FeLV protease is a viral-encoded enzyme with conserved specificity among leukemia viruses.
  • Its location within the pol gene and unique synthesis pathway are key features.
  • Understanding FeLV protease function is vital for developing antiviral strategies.

Related Concept Videos